Reference is made to the following disclosures by IDEX Biometrics ASA: 15 June 2025: Issue of 299,381,600 new shares to employees, contractors and directors in IDEX.23 June 2025: Issue of 5,412,932 new shares in lieu of cash board remuneration as approved by the annual general meeting held on 21 May 2025.23 June 2025: Issue of 69 new shares to an employee to facilitate the 100-to-1 share consolidation as resolved by the extraordinary general meeting held on 11 April 2025. The share capital increases have be ...

The Supervisory Board of AS Harju Elekter Group decided to increase the share capital of the company by 17,010 euros by issuing new ordinary shares. The increase in the share capital is due to the need to issue new shares to the management board members and key personnel of Harju Elekter and its subsidiaries participating in the option program approved with the resolution of the general meeting on 29 April 2021. A total of 4 current and former employees of Harju Elekter participated in the share issue relat ...

Core Viewpoint - IDEX Biometrics ASA's board has approved the issuance of 299,381,600 new shares at NOK 0.01 per share to incentivize personnel in implementing the amended business plan and commercializing the company's products [1][2]. Group 1: Share Issuance Details - The share issuance is part of a Personnel Placement authorized by an extraordinary general meeting held on 11 April 2025, which also approved terms for debt conversion [2]. - The shares will be restricted for 18 months post-issuance, with 1/3 released after 6 months and another 1/3 after 12 months [3]. - The company retains the right to repurchase restricted shares if a holder resigns or is terminated [3]. Group 2: Compliance and Impact - The board has ensured that the Personnel Placement complies with equal treatment obligations under relevant Norwegian laws and Oslo Stock Exchange rules [4]. - The number of new shares represents approximately 6.7% of the total outstanding shares, with a limited dilutive effect on existing shareholders [4]. - The subscription price of NOK 0.01 represents a 78% discount to the closing price on 13 June 2025, with potential variations in discount due to the lock-up period and share volatility [4]. Group 3: Company Overview - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [6]. - The company's biometric solutions are built on patented technologies and target card-based applications for payments and digital authentication [6].

Reference is made to the announcement of Heimar hf. (“Heimar” or the “Company”) dated 23 April 2025 regarding the Company’s acquisition of all shares in Gróska ehf. and Gróðurhúsið ehf. As previously announced, the purchase price shall be settled through the issuance and delivery of 258 million new shares in Heimar. The Board of Directors of Heimar has resolved to issue new share capital in the nominal amount of ISK 258,000,000. As a result, the Company’s share capital will increase from ISK 1,763,901,137 t ...

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 June 2025 – 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of the exercise of subscription rights, 85,000 new shares have been issued on 6 June 2025. In accordance with the Belgian transparency legislation, Fagron notes that its total share capital currently amounts to € 504,303,905.59. The total number of shares with voting rights after the issue amounts to 73,313,904 which ...

Core Viewpoint - IDEX Biometrics ASA has successfully completed a Subsequent Offering of up to 600,000,000 new shares, which was 8 times oversubscribed, raising gross proceeds of NOK 6 million [3]. Company Information - IDEX Biometrics ASA is a global technology leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [13]. - The company's biometric solutions are built on patented sensor technologies and target card-based applications for payments and digital authentication [13]. Offering Details - The Subscription Period for the Subsequent Offering commenced on 22 May 2025 and expired on 5 June 2025 [2]. - The total number of Offer Shares allocated was 600,000,000 at a subscription price of NOK 0.01 per share [3]. - The share capital increase related to the Subsequent Offering is expected to be registered in the Norwegian Register of Business Enterprises on or about 13 June 2025, resulting in a total share capital of NOK 44,316,309.99 [5]. Shareholder Information - Investors allocated Offer Shares can access their allocation information through VPS on or about 6 June 2025, with payment due on 11 June 2025 [4]. - The Offer Shares will rank equally with the company's existing shares [6].

The annual general meeting of shareholders of Arco Vara AS held on 5 June 2025 adopted the following decisions: To approve the annual report of Arco Vara AS for 2024.To cover the net loss of EUR 624 thousand for the financial year ended on 31.12.2024 from retained earnings; and to pay a dividend of EUR 0.02 per share. The dividend of EUR 0.02 per share will be paid to shareholders on 12 November 2025 via transfer to the shareholder’s bank account. The list of shareholders entitled to receive the dividend (r ...

Reference is made to the announcement by IDEX Biometrics ASA on 5 May 2025 regarding the results of the exercise of Warrants B. A total of 36,767 Warrants B were exercised, resulting in an aggregate subscription for 36,767 new shares, each Warrant B having an exercise price of NOK 0.15. The share capital increase has duly been registered in the Norwegian Register of Business Enterprises. Following the share capital increase, the company's share capital will be NOK 38,316,309.99, divided into 3,831,630,999 s ...

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 12 December 2024 regarding the listing of Warrants A and Warrants B on Oslo Stock Exchange. Warrants B were exercisable between 31 March 2025 and 11 April 2025, and all Warrants B not exercised within such time lapsed without compensation to the holder. A total of 36,767 Warrants B were exercised, resulting in an aggregate subscription for 36,767 new shares (the "New Shares") in the Company, each Warrant B having an exercise pri ...